Tremblant Capital Group / ALNY
Tremblant Capital Group’s Alnylam Pharmaceuticals Inc Position
Does Tremblant Capital Group own Alnylam Pharmaceuticals Inc (ALNY)? Yes — 94.6K shares worth $31M (+1.01% of its 13F portfolio) as of Q1 2026, down from 110.1K shares the prior filed quarter.
Position Value
$31M
Q1 2026
Shares
94.6K
% of Portfolio
+1.01%
Quarters Held
2
currently held
Position History ALNY
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tremblant Capital Group’s full portfolio or all institutional holders of ALNY.